New Delhi: Sakar Healthcare on Saturday reported a jump in net profit to Rs 10.28 crore during the first quarter of 2026-27. The company had posted a net profit of Rs 4.67 crore in the same quarter of the last year, a company statement said. The company reported a 38 per cent rise in revenue from operations to Rs 72.97 crore during the quarter compared to Rs 52.73 crore in Q1 FY26. Sanjay Shah, Managing Director of Sakar Healthcare, said, "Our oncology business remains a key pillar of our strategy. During the quarter, we expanded commercial engagements, strengthened export momentum, and advanced dossier submissions, marketing authorisations, site variation approvals, and technology transfer projects with leading global pharmaceutical partners." Sakar Healthcare Ltd is a listed pharmaceutical manufacturer and exporter specialising in oncology, antibiotics, and general formulations. During the quarter, the company executed more than 65 oncology product contracts, with over 50 commercial discussions currently underway, it said. PTI